Find a story
Search Spins
Search titles, summaries, and missing voices across published articles — press releases, announcements, and media coverage.
6 results for “drug development”
Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'
Kalshi and Polymarket launched prediction markets tied to clinical trial outcomes, drawing criticism from researchers who argue such markets risk enabling insider trading and distorting drug development incentives, while the platforms counter that they improve patient access to trial information.
Aug 8, 2026
Doctors and researchers worry that FDA-related wagers on Kalshi and Polymarket could compromise drug development tests and erode public trust in the process (Rebecca Robbins/New York Times)
Medical professionals and researchers express concern that prediction markets like Kalshi and Polymarket—where users bet on FDA regulatory decisions—are creating perverse incentives that could distort clinical trial design, influence drug development priorities, and undermine public confidence in the FDA approval process.
Jul 29, 2026
How AI is supercharging drug development - Axios
The article reports on AI's accelerating role in drug discovery and development, highlighting speed, cost reduction, and novel target identification — but provides no specific case studies, timelines, or validation metrics.
Published Jul 20, 2026 · Analyzed Aug 3, 2026
Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable
Anthropic has announced it is initiating internal drug discovery programs targeting diseases deemed unprofitable by major pharmaceutical companies, positioning itself as a non-commercial actor in biomedical R&D.
Published Jul 4, 2026 · Analyzed Jul 6, 2026
How a Google DeepMind Spin-off Hunts Hidden Drug Targets
Isomorphic Labs, a Google DeepMind spin-off, launched its Isomorphic Drug Design Engine (IsoDDE) to improve AI-driven drug discovery by predicting protein-ligand interactions, pocket identification, and binding affinity—addressing limitations of AlphaFold3 in novel target spaces.
Published Jun 11, 2026 · Analyzed Jul 4, 2026
How AI may speed up drug development - Axios
The article reports on speculative potential for AI to accelerate drug development timelines and reduce costs, without citing specific trials, validated models, or regulatory approvals.
Published Jul 16, 2019 · Analyzed Jul 6, 2026